Cyrix
Press Release

Cyrix Completes Transition Year

New Processors Launched

Richardson, Texas -- January 18, 1996 -- Cyrix Corporation (NASDAQ: CYRX) today reported revenues of $228 million for 1995, down 7 percent compared to the previous year. The Company reported net income of $15.6 million for 1995, down from $37.6 million in 1994. On a per-share basis, the Company earned $0.78 for the year, compared to $1.88 in the same period last year.

Net sales for the final quarter of 1995 were $39 million, down from the fourth quarter 1994 net sales of $73 million by 47 percent as demand and pricing for 486 products decreased substantially. Cyrix posted a net loss of $9.9 million for the fourth quarter of 1995. On a per-share basis, Cyrix recorded a loss in the fourth quarter 1995 of $0.49 compared to a net income of $0.63 in fourth quarter 1994. Although the loss put Cyrix into default of covenants contained in its credit agreements, waivers have been obtained from each of the creditors.

"While our financial performance in 1995 failed to reflect growth over the previous year, the introduction of two wholly original microprocessor architectures by Cyrix was a first for the industry," said Jerry Rogers, Cyrix president and chief executive officer. "With the introduction of the 5x86™ in July and the 6x86™ in October, Cyrix became the only viable alternative to Intel in the x86 marketplace and demonstrated its preeminence in the design of original, fully-compatible processors. Our challenge in 1996 is to produce and sell as many 6x86 processors as possible and to expand our customer base," Rogers said.

Cyrix Corporation, headquartered in Richardson, Texas, is a leading supplier of high-performance processors to the personal computer industry. Founded in 1988, the Company designs, manufactures and markets innovative, x86 software-compatible processors for the desktop and mobile computer markets. Cyrix is a publicly-held company traded on NASDAQ. Forward-looking statements involve risks relative to market demand and acceptance, the impact of changing economic conditions, the impact of market peers and their products as well as risks concerning future technology and others detailed in the Company's Securities and Exchange Commission filings. These filings can be obtained by contacting Cyrix Investor Relations.


Consolidated Balance Sheet

(in thousands)

                                                      December 31,     December 31,
                                                           1995             1994
                                                      ------------------------------
Assets
Cash, cash equivalents and investments                 $  44,334        $  59,241
Accounts receivable, net                                  44,727           41,995
Inventories                                               12,274           18,477
Deferred taxes and other assets                           27,644           12,455
                                                       -----------------------------
Total current assets                                     128,979          132,168
Net property and equipment                                98,307           38,047
Prepayments for product purchases,
   less current portion                                   40,697           23,330
Deferred taxes and other assets                              802            2,589
                                                       -----------------------------
Total assets                                           $ 268,785        $ 196,134
                                                       =============================

Liabilities and Stockholders' Equity
Accounts payable                                       $  15,239        $  27,180
Deferred income and distributor reserves                  15,526            4,558
Income taxes payable                                         536            2,644
Current maturities of long-term debt and
   capitalized lease obligations                          20,053            4,544
Deferred litigation settlement                                --            5,000
Other accrued expenses                                     9,113            8,227
                                                       -----------------------------
Current liabilities                                       60,467           52,153
Long-term debt, less current maturities                   62,325           18,253
                                                       -----------------------------
Total liabilities                                        122,792           70,406
Stockholders' equity                                     145,993          125,728
                                                       -----------------------------
Total liabilities and stockholders' equity             $ 268,785        $ 196,134
                                                       =============================


Consolidated Statements of Income

(in thousands, except for earnings per share)

                                         Quarter ended Dec. 31,         Year ended Dec. 31,
                                             1995       1994             1995       1994
                                        ----------------------      ----------------------
Net sales                                $  36,415  $  73,024        $ 210,294  $ 246,098
Royalty revenue                              2,644         --           17,718         --
                                        ----------------------      ----------------------
Net revenues                                39,059     73,024          228,012    246,098
Cost of sales                               36,101     36,491          142,063    120,721
                                        ----------------------      ----------------------
Gross margin                                 2,958     36,533           85,949    125,377
                                        ----------------------      ----------------------
Marketing, general and administrative        9,963     11,037           39,099     44,858
Research and development                     7,235      6,275           29,115     24,755
                                        ----------------------      ----------------------
Total operating expenses                    17,198     17,312           68,214     69,613
                                        ----------------------      ----------------------
Income from operations                     (14,240)    19,221           17,735     55,764
Income from litigation settlement               --         --           10,000        500
Net interest income (expense)               (1,388)       277           (3,959)     1,134
                                        ----------------------      ----------------------
Income before taxes                        (15,628)    19,498           23,776     57,398
Taxes on income                             (5,704)     6,833            8,164     19,821
                                        ----------------------      ----------------------
Net income                               $  (9,924)  $ 12,665        $  15,612   $ 37,577
                                        ======================      ======================
Net income per common and common
   equivalent share                         $(0.49)     $0.63            $0.78      $1.88
                                        ======================      ======================
Weighted average common and common
  equivalent shares outstanding             20,212     20,031           19,985     19,986


| About Cyrix | Annual Report | Press Room | Investor Relations | Careers @ Cyrix | Page Top |
| Product Info | Corporate Info | Contact | Index | Text Only | Home |

Copyright & Legal Info © 1995-1997 by Cyrix Corporation, Richardson, TX, U.S.A.